See All Slides - tctmd.com

Slides

Presentation TCT 2012

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Presenter: Dimitri Karmpaliotis

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

Introduction(14)

Presenter: Sigmund Silber

October 22, 2012

Presentation TCT 2012

Relative Frequency and Implication of Periprocedural vs. Spontaneous MI

Presenter: Sripal Bangalore

October 22, 2012

Presentation TCT 2012

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Presenter: Allan Jaffe

October 22, 2012

Presentation TCT 2012

Evidence/Practice Intersection: What We Know, What We Don't, and How to Treat

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

From Hardware (Devices) to Software (Information Technology): How the Digital Revolution Will Change Medical Innovation

Presenter: Peter Fitzgerald

October 22, 2012

Presentation TCT 2012

Non-Left Main Bifurcation PCI: Integrated Use of FFR and IVUS

Presenter: Soo-Jin Kang

October 22, 2012

Presentation TCT 2012

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

Presenter: David Cormode

October 22, 2012

Presentation TCT 2012

RESPECT: Late Breaking Trial Preview

Presenter: John Carroll

October 22, 2012

Advertisement

Slides

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Introduction(14)

Relative Frequency and Implication of Periprocedural vs. Spontaneous MI

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Evidence/Practice Intersection: What We Know, What We Don't, and How to Treat

From Hardware (Devices) to Software (Information Technology): How the Digital Revolution Will Change Medical Innovation

Non-Left Main Bifurcation PCI: Integrated Use of FFR and IVUS

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

RESPECT: Late Breaking Trial Preview

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content